reclassify Marinol (dronabinol) from Schedule II to Schedule III
The DEA is proposing to reclassify Marinol (dronabinol) from Schedule II to Schedule III.
Marinol is a synthetic form of THC...the active ingredient in marijuana. It's used for nausea or to improve appetite in patients with cancer or AIDS.
Marinol has a low potential for abuse. Its slow onset doesn't produce the same high that people get from smoking marijuana.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber's Letter includes:
- 12 issues every year, with brief articles about new meds and guidelines
- 48+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote